This inventor holds 7 USPTO granted patents. Top assignees: Research Development Corporation of Japan, Suntory Limited, Ueno Seiyaku Kabushikikaisha. Active years: 1988-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1988-2009
Title: Osamu Hayaishi: A Pioneer in Prostaglandin Research
Introduction
Osamu Hayaishi is a distinguished inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of prostaglandins. With a total of seven patents to his name, Hayaishi's work has had a profound impact on medical science.
Latest Patents
Hayaishi's latest patents include innovative methods and structures that advance the understanding of prostaglandin D synthase. One notable patent describes a three-dimensional structure of prostaglandin D synthase and its utilization in designing anti-allergic agents, sleep-controlling agents, anti-obesity agents, and remedies for brain injury. This method acts via the inhibition of biosynthesis of prostaglandin D. Another significant patent involves the use of sex hormones for treating immunodeficiency diseases, which comprises administering a therapeutically effective amount of sex hormone to a subject in need of such treatment.
Career Highlights
Throughout his career, Hayaishi has worked with prominent organizations, including the Research Development Corporation of Japan and Suntory Limited. His research has been pivotal in advancing the understanding of prostaglandin functions and their therapeutic applications.
Collaborations
Hayaishi has collaborated with notable colleagues such as Hiroshi Naruse and Masashi Takesada. Their combined expertise has contributed to the success of various research projects and patents.
Conclusion
Osamu Hayaishi's innovative work in the field of prostaglandin research has led to significant advancements in medical treatments. His contributions continue to influence the scientific community and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile